About Finekem Laboratories Private Limited
Data last updated:
Finekem Laboratories Private Limited was a private limited company based in Aurangabad, Maharashtra, India, operated as a subsidiary of Amri India Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the chemical products segment of the chemicals sector. It was incorporated on 05 February 2003.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2003PTC139025. Its GSTIN is 27AAACF7563Q1ZY (Maharashtra).
The company had an authorised share capital of ₹50 Lakh and a paid-up capital of ₹33.85 Lakh. It was led by directors including Murali Krishna Valluri and Benjamin Seisler.
Its last annual general meeting (AGM) was held on 27 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at Plot No. 39/5 MIDC Industrial Area Waluj, Aurangabad, Maharashtra, India – 431133.
As per the financials filed for FY 2017, the company reported a revenue of ₹28.16 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹4.18 Cr (net margin 14.9%) and EBITDA of ₹6.66 Cr (EBITDA margin 23.7%).
As per MCA filings, the company had satisfied charges of ₹3.5 Cr on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it; 1 case is pending.
The last known website on record is amriglobal.com.
Company details
Contact details
Finekem Laboratories Private Limited's registered office is in Aurangabad, Maharashtra. Its website is amriglobal.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 39/5 MIDC Industrial Area Waluj, Aurangabad, Maharashtra, India – 431133
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Finekem Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Finekem Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Finekem Laboratories Private Limited, buy the company report.
Financials of Finekem Laboratories Private Limited
FY 2017 filings availableFinekem Laboratories Private Limited reported revenue of ₹28.16 Cr (up 164% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue rose 164% in the latest year. EBITDA rose 468% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹28.16 Cr | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹6.66 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹4.18 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 23.7% | ||
| Net Profit Margin | 14.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Finekem Laboratories Private Limited, buy the company report.
Board of directors of Finekem Laboratories Private Limited
Finekem Laboratories has 5 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Murali Krishna Valluri Also directs: Kompally Junction Private Limited, Curia India Private Limited | Director | 19 Apr 2017 | 9 Years 6 Months | As last reported |
| Subir Kumar Sadhukhan | Additional Director | 07 Aug 2018 | 8 Years 2 Months | As last reported |
| Mariesa Beth Coppola Also directs: Curia India Private Limited | Additional Director | 13 Dec 2017 | 8 Years 10 Months | As last reported |
| Benjamin Seisler | Director | 21 Jul 2017 | 9 Years 3 Months | As last reported |
| Prakash Abichandani | Director | 30 Aug 2018 | 8 Years 1 Months | As last reported |
Peer comparison
Finekem Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Leena Organics Private Limited | ₹28.26 Cr (FY 2024) | 5.0% | Delhi, India | |||
| Maxwell Additives Private Limited | ₹28.25 Cr (FY 2024) | 0.0% | Vadodara, Gujarat, India | |||
| Parmax Pharma Limited | ₹28.24 Cr (FY 2025) | 154.0% | Hadamtala, Gujarat, India | |||
| Harlequin Paints Private Limited | ₹28.22 Cr (FY 2025) | 8.0% | Mumbai, Maharashtra, India | |||
| Guljag Health Care Private Limited | ₹28.21 Cr (FY 2025) | -25.0% | Mumbai, Maharashtra, India | |||
| Finekem Laboratories Private Limitedthis company | ₹28.16 Cr (FY 2017) | ₹4.18 Cr | 14.9% | 164.0% | Aurangabad, Maharashtra, India | |
| Indus Pharma Private Limited | ₹28.11 Cr (FY 2023) | -58.0% | New Delhi, Delhi, India | |||
| Sriyaan Chemicals Private Limited | ₹28.07 Cr (FY 2025) | 195.0% | Ankleshwar, Gujarat, India | |||
| PMD Petrocem India Private Limited | ₹28.06 Cr (FY 2020) | 31.0% | Amritsar, Punjab, India | |||
| Goldline Pharmaceutical Limited | ₹28.06 Cr (FY 2025) | 19.0% | Nagpur, Maharashtra, India | |||
| Inven Pharmaceuticals Private Limited | ₹27.99 Cr (FY 2025) | -6.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Finekem Laboratories Private Limited, buy the company report.
Auditor
Finekem Laboratories Private Limited is audited by BSR & ASSOCIATES LLP for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BSR & ASSOCIATES LLP | FY 2017 | 116231W/W100024 |
Shareholding
The shareholding of Finekem Laboratories Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Finekem Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Dec 2005 | 80005095 | Bank of India | ₹1.5 Cr | Satisfied | |
| 28 Nov 2005 | 80005093 | Bank of India | ₹2 Cr | Satisfied |
To see the full charge records of Finekem Laboratories Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Finekem Laboratories Private Limited has 3 court cases on record: 1 filed by Finekem Laboratories, 2 filed against it. 1 case is pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
| High courts | 1 | 0 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (COMPLAINT ULP) | Filed against the company by an individual | Pending |
| Bombay High Court | Court case (CSD) | Filed by the company | Disposed |
| District court, Aurangabad, Maharashtra | Civil suit | Filed against the company by an individual | Disposed |
To see the full case history of Finekem Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Finekem Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Finekem Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACF7563Q1ZY | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Finekem Laboratories Private Limited, buy the company report.
Recent activity
Finekem Laboratories Private Limited has 21 board changes on record since 2008: 5 appointments and 16 cessations. The latest: Prakash Abichandani was appointed as Director on 30 Aug 2018.
18 earlier events are in the company report.
Frequently asked questions
Finekem Laboratories has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Finekem Laboratories was a private limited company based in Aurangabad, Maharashtra, India. The company worked in chemical products, within the chemicals industry. It was incorporated on 05 February 2003 and is registered under CIN U24110MH2003PTC139025. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Finekem Laboratories was incorporated on 05 February 2003. It is registered with the Registrar of Companies, Mumbai.
Finekem Laboratories had 5 directors:
- Murali Krishna Valluri - Director
- Subir Kumar Sadhukhan - Additional Director
- Mariesa Beth Coppola - Additional Director
- Benjamin Seisler - Director
- Prakash Abichandani - Director
The CIN (Corporate Identification Number) of Finekem Laboratories is U24110MH2003PTC139025. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Finekem Laboratories is at Plot No. 395 MIDC Industrial Area Waluj, Aurangabad, Maharashtra, India – 431133.
Finekem Laboratories can be reached through the website amriglobal.com. Its registered office is in Aurangabad, Maharashtra, India.
The latest financial statements of Finekem Laboratories on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 27 September 2017. Year-wise statements from 2015 are in the company report.
The GSTIN of Finekem Laboratories is 27AAACF7563Q1ZY, registered in Maharashtra.
Finekem Laboratories operated in the chemicals industry, in the chemical products segment.
The peers of Finekem Laboratories by revenue are Leena Organics Private Limited, Maxwell Additives Private Limited, Parmax Pharma Limited, Harlequin Paints Private Limited, Guljag Health Care Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).